Related Experiment Video
Updated: Mar 9, 2026

Multiplex PCR Assay for Typing of Staphylococcal Cassette Chromosome Mec Types I to V in Methicillin-resistant Staphylococcus aureus
Published on: September 5, 2013
Multicenter Study of the Clinical Presentation of Staphylococcus lugdunensis Bacteremia in Japan
Yusuke Ainoda1,2,3, Nozomi Takeshita1, Ryota Hase4,5
1Disease Control and Prevention Center, National Center for Global Health and Medicine.
Abstract:
Staphylococcus lugdunensis (SL) is a bacterium with a highly pathogenicity than most other coagulase-negative Staphylococcus spp. (CoNS). In Japan, data on this pathogen are sparse, and the current prevalence of SL bacteremia is unknown. Therefore, we investigated the prevalence of SL in blood culture specimens in a prospective multicenter study across 5 facilities. A total of 3,284 patients had positive blood cultures, and 2,478 patients had bacteremia. Among the patients with bacteremia, 7 patients (0.28%) had SL bacteremia. A total of 281 patients had CoNS bacteremia, with SL accounting for 2.49% of these cases. Of the 7 patients with SL bacteremia, 1 patient (14.3%) had infective endocarditis, and 1 patient (14.3%) died within 30 days. In this study, SL resulted in the development of bacteremia in select patients. Clinicians in Japan should be aware of the prevalence of SL and the complications of SL bacteremia.
Insights
Staphylococcus lugdunensis (SL) bacteremia is rare but serious in Japan. This study found SL in 0.28% of bacteremia cases, highlighting the need for clinical awareness of this pathogen.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Medicine
Background:
- Staphylococcus lugdunensis (SL) is a coagulase-negative Staphylococcus species (CoNS) with notable pathogenicity.
- Limited data exist on the prevalence and clinical significance of SL in Japan.
- The current prevalence of SL bacteremia in Japan remains unknown.
Purpose of the Study:
- To determine the prevalence of Staphylococcus lugdunensis bacteremia in Japan.
- To assess the clinical characteristics and outcomes of SL bacteremia.
Main Methods:
- A prospective, multicenter study was conducted across 5 healthcare facilities.
- Blood culture specimens from 3,284 patients with positive cultures were analyzed.
- Patients with bacteremia were identified, and the proportion of SL bacteremia was calculated.
Main Results:
- Out of 2,478 patients with bacteremia, 7 (0.28%) had SL bacteremia.
- SL accounted for 2.49% of all coagulase-negative Staphylococcus spp. (CoNS) bacteremia cases (281 total).
- One patient (14.3%) developed infective endocarditis, and another (14.3%) died within 30 days.
Conclusions:
- Staphylococcus lugdunensis can cause bacteremia in Japanese patients.
- Clinicians should be aware of SL's prevalence and potential complications, including infective endocarditis and mortality.
- Further surveillance and research are warranted to understand SL epidemiology in Japan.
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Pyelonephritis II: Diagnostic Studies and Management
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...

